Speech-Language Pathologists in Lubbock, TN Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Shelley Rene King, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5225 South Loope 289, Ste 210, Lubbock, TN 79424 Phone: 806-780-4180 Fax: 806-744-7458 |
News Archive
Women with MET genetic variant and autoantibodies more likely to have autistic children
A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.
Researchers examine impact of losing multiple senses on older adults
It's a well-known fact that aging can lead to losing one's senses: vision, smell, hearing, touch, and taste. In previous studies, researchers have learned about the consequences of experiencing a decline in a single sense. For example, losing senses of smell, vision, and hearing have all been linked to cognitive decline, poor mental health, and increased mortality.
Evidence of exposure to a monkey virus possibly related to cancer has been found in the blood of North American zoo workers
The virus, a polyomavirus known as simian virus 40 (SV40), has long been a subject of public health concern, in part because it has been shown to cause cancer in laboratory animals, and some investigators have reported SV40 DNA in human tumors.
Watson introduces Amethia Lo and ethinyl estradiol tablets
Watson Pharmaceuticals, Inc. today announced that under a settlement with Teva Women's Health, Watson has launched Amethia Lo (levonorgestrel/ethinyl estradiol (0.1mg/0.02mg) and ethinyl estradiol (0.01mg)) tablets, the generic equivalent of Teva Women's Health, Inc.'s LoSEASONIQUE.
CPRIT awards Bellicum $5.7 million to advance CaspaCIDe therapy for late stage cancer
Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this second round of the commercialization award program.
› Verified 8 days ago